Cargando…

Early contribution of germline and nevi genetic alterations to a rapidly-progressing cutaneous melanoma patient: a case report

BACKGROUND: Cutaneous melanoma is the skin cancer with the highest mutational burden and metastatic rate. Early genetic alterations and biomarkers of distant progression are a point of interest. In addition to germline-susceptibility loci, almost 30% of melanomas arise from precursor benign nevi les...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mordoh, Ana, Triviño Pardo, Juan Carlos, Carri, Ibel, Barrio, María Marcela, Mordoh, José, Aris, Mariana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9814418/ https://www.ncbi.nlm.nih.gov/pubmed/36604730 http://dx.doi.org/10.1186/s12920-022-01426-2

Ejemplares similares

An Update of Cutaneous Melanoma Patients Treated in Adjuvancy With the Allogeneic Melanoma Vaccine VACCIMEL and Presentation of a Selected Case Report With In-Transit Metastases
por: Mordoh, Ana, et al.
Publicado: (2022)

Lessons from Cancer Immunoediting in Cutaneous Melanoma
por: Aris, Mariana, et al.
Publicado: (2012)

Immunomodulatory Monoclonal Antibodies in Combined Immunotherapy Trials for Cutaneous Melanoma
por: Aris, Mariana, et al.
Publicado: (2017)

Changes in the TCRβ Repertoire and Tumor Immune Signature From a Cutaneous Melanoma Patient Immunized With the CSF-470 Vaccine: A Case Report
por: Aris, Mariana, et al.
Publicado: (2018)

Inoculation Site from a Cutaneous Melanoma Patient Treated with an Allogeneic Therapeutic Vaccine: A Case Report
por: Aris, Mariana, et al.
Publicado: (2015)

Evaluation of T-Cell Responses Against Shared Melanoma Associated Antigens and Predicted Neoantigens in Cutaneous Melanoma Patients Treated With the CSF-470 Allogeneic Cell Vaccine Plus BCG and GM-CSF
por: Podaza, Enrique, et al.
Publicado: (2020)

Immunization With the CSF-470 Vaccine Plus BCG and rhGM-CSF Induced in a Cutaneous Melanoma Patient a TCRβ Repertoire Found at Vaccination Site and Tumor Infiltrating Lymphocytes That Persisted in Blood
por: Aris, Mariana, et al.
Publicado: (2019)

HEV-associated dendritic cells are observed in metastatic tumor-draining lymph nodes of cutaneous melanoma patients with longer distant metastasis-free survival after adjuvant immunotherapy
por: Bravo, Alicia Inés, et al.
Publicado: (2023)

A word of caution: do not wake sleeping dogs; micrometastases of melanoma suddenly grew after progesterone treatment
por: Mordoh, Jose, et al.
Publicado: (2013)

The risk of cutaneous melanoma in melanocytic nevi
por: Fernandes, Nurimar Conceição
Publicado: (2013)

Melanocytic nevi in sentinel lymph nodes: association with cutaneous nevi and clinical relevance in patients with cutaneous melanomas
por: Kretschmer, Lutz, et al.
Publicado: (2022)

Editorial: “Cancer Immunotherapy: Lights and Shadows”
por: Barrio, María Marcela, et al.
Publicado: (2015)

Nevi, dysplastic nevi, and melanoma: Molecular and immune mechanisms involving the progression
por: Sung, Wei-Wen, et al.
Publicado: (2021)

Preoperative measurement of cutaneous melanoma and nevi thickness with photoacoustic imaging
por: Breathnach, Aedán, et al.
Publicado: (2018)

The Interplay between Nevi and Melanoma Predisposition Unravels Nevi-Related and Nevi-Resistant Familial Melanoma
por: Pellegrini, Stefania, et al.
Publicado: (2021)

Dissecting the Immune Stimulation Promoted by CSF-470 Vaccine Plus Adjuvants in Cutaneous Melanoma Patients: Long Term Antitumor Immunity and Short Term Release of Acute Inflammatory Reactants
por: Pampena, María B., et al.
Publicado: (2018)

Mechanical Properties of Growing Melanocytic Nevi and the Progression to Melanoma
por: Taloni, Alessandro, et al.
Publicado: (2014)

NRAS and BRAF Mutations in Melanoma-Associated Nevi and Uninvolved Nevi
por: Tschandl, Philipp, et al.
Publicado: (2013)

Human Macrophages and Dendritic Cells Can Equally Present MART-1 Antigen to CD8(+) T Cells after Phagocytosis of Gamma-Irradiated Melanoma Cells
por: Barrio, María Marcela, et al.
Publicado: (2012)

Spitz nevi and Spitzoid melanomas - Exome sequencing and comparison to conventional melanocytic nevi and melanomas
por: Lazova, Rossitza, et al.
Publicado: (2017)

Melanoma Vaccines and Modulation of the Immune System in the Clinical Setting: Building from New Realities
por: Madorsky-Rowdo, Florencia Paula, et al.
Publicado: (2012)

A murine model for the development of melanocytic nevi and their progression to melanoma
por: Nasti, Tahseen H., et al.
Publicado: (2015)

Epigenetic inhibitors eliminate senescent melanoma BRAFV600E cells that survive long-term BRAF inhibition
por: Rowdo, Florencia Paula Madorsky, et al.
Publicado: (2020)

Phase II Study of Adjuvant Immunotherapy with the CSF-470 Vaccine Plus Bacillus Calmette–Guerin Plus Recombinant Human Granulocyte Macrophage-Colony Stimulating Factor vs Medium-Dose Interferon Alpha 2B in Stages IIB, IIC, and III Cutaneous Melanoma Patients: A Single Institution, Randomized Study
por: Mordoh, José, et al.
Publicado: (2017)

RETINAL OXIMETRY IS ALTERED IN EYES WITH CHOROIDAL MELANOMA BUT NOT IN EYES WITH CHOROIDAL NEVI
por: Brouwer, Niels J., et al.
Publicado: (2020)

Transcriptome Analysis Reveals the Molecular Immunological Characteristics of Lesions in Patients with Halo Nevi When Compared to Stable Vitiligo, Normal Nevocytic Nevi and Cutaneous Melanoma
por: Pan, Chun, et al.
Publicado: (2021)

On the Interplay of Telomeres, Nevi and the Risk of Melanoma
por: Bodelon, Clara, et al.
Publicado: (2012)

Intra‐nodal nevi in sentinel node‐negative patients with cutaneous melanoma does not influence survival
por: de Beer, F.S.A., et al.
Publicado: (2019)

Combining Immunotherapy with Oncogene-Targeted Therapy: A New Road for Melanoma Treatment
por: Aris, Mariana, et al.
Publicado: (2015)

Protein expression changes during human triple negative breast cancer cell line progression to lymph node metastasis in a xenografted model in nude mice
por: Roberti, María Paula, et al.
Publicado: (2012)

Glycoproteomic characterization of carriers of the CD15/Lewis(x )epitope on Hodgkin's Reed-Sternberg cells
por: Powlesland, Alex S, et al.
Publicado: (2011)

CKS1 expression in melanocytic nevi and melanoma
por: Brożyna, Anna A., et al.
Publicado: (2017)

Early Events of the Reaction Elicited by CSF-470 Melanoma Vaccine Plus Adjuvants: An In Vitro Analysis of Immune Recruitment and Cytokine Release
por: Pampena, María B., et al.
Publicado: (2017)

Neurocristic cutaneous hamartoma of the scalp with disseminated melanocytic nevi
por: Mariki, Haika, et al.
Publicado: (2023)

In vitro long-term treatment with MAPK inhibitors induces melanoma cells with resistance plasticity to inhibitors while retaining sensitivity to CD8 T cells
por: Rowdo, Florencia Paula Madorsky, et al.
Publicado: (2017)

A phase I clinical study of vaccination of melanoma patients with dendritic cells loaded with allogeneic apoptotic/necrotic melanoma cells. Analysis of toxicity and immune response to the vaccine and of IL-10 -1082 promoter genotype as predictor of disease progression
por: von Euw, Erika M, et al.
Publicado: (2008)

Halo Nevi Are Not Trivial: About 2 Young Patients of Regressed Primary Melanoma That Simulates Halo Nevi
por: De Schrijver, S., et al.
Publicado: (2021)

Involvement of mutant and wild-type CYSLTR2 in the development and progression of uveal nevi and melanoma
por: Nell, Rogier J., et al.
Publicado: (2021)

Shared Gene Expression and Immune Pathway Changes Associated with Progression from Nevi to Melanoma
por: Borden, Elizabeth S., et al.
Publicado: (2021)

Rapid regression of multiple melanocytic nevi in an individual with history of melanoma with the CDKN2A mutation
por: Jaber, Nor Fazil, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_amd5gdmojmolbo0dilkmetl2g3